Skip to main content

Peripheral Arterial Disease News

Related terms: Peripheral Artery Disease, Peripheral Vascular Disease

Updated Guidance Issued for Managing Lower-Extremity Peripheral Artery Disease

MONDAY, May 20, 2024 – In a clinical practice guideline issued by the American Heart Association, the American College of Cardiology, and nine other medical societies, updated recommendations are...

Key Therapy Equally Effective for Women, Men With Narrowed Leg Arteries

FRIDAY, May 3, 2024 – Peripheral artery disease (PAD) involves a debilitating narrowing of arteries in the legs, and the National Institutes of Health estimates that 1 in every 20 Americans over 50...

Heart Attack Survivorship Tied to Long-Term Health Consequences

MONDAY, March 4, 2024 – Heart attacks are associated with an increased risk for developing other serious health conditions, such as peripheral arterial disease, renal failure, diabetes, and...

FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)

TITUSVILLE, NJ, October 11, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to r...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Conditions and Disorders

Related drug support groups

Xarelto, Plavix, clopidogrel